- How is NIEHS/NTP Researching the Health Effects of BPA?
- NIEHS Awarded Recovery Act Funds to Address Bisphenol A Research Gaps
- Why did NIEHS use Recovery funds to support BPA research?
- What impact will the Recovery funding focused on BPA have?
- What did NTP conclude in its 2008 monograph?
- Related Links
Bisphenol A (BPA)
Bisphenol A (BPA) is a chemical produced in large quantities for use primarily in the production of polycarbonate plastics and epoxy resins.
One reason people may be concerned about BPA is because human exposure to BPA is widespread. The 2003-2004 National Health and Nutrition Examination Survey (NHANES III) conducted by the Centers for Disease Control and Prevention (CDC) found detectable levels of BPA in 93% of 2517 urine samples from people six years and older. The CDC NHANES data are considered representative of exposures in the United States. Another reason for concern, especially for parents, may be because some animal studies report effects in fetuses and newborns exposed to BPA.
This content is available to use on your website.
Please visit NIEHS Syndication to get started.
How is NIEHS/NTP Researching the Health Effects of BPA?
The National Institute of Environmental Health Sciences (NIEHS) and National Toxicology Program (NTP) have developed an integrated, multipronged, consortium-based approach to optimize BPA-focused research investments to more effectively address data gaps and inform decision making.
NIEHS/NTP BPA research investments made over the past four years include extramural research grants, establishment of a BPA Grantee Consortium, intramural research activities on BPA's mechanisms of action, launch of two clinical studies and an occupational study, development of a round robin experiment to validate BPA measurements in human serum, and, in collaboration with the Food and Drug Administration (FDA), formation of a consortium to design and execute a chronic toxicity study of BPA in rats.
NIEHS's new consortium-based approach has led to more integrated, collaborative efforts and should improve our ability to resolve controversies over the potential human health effects of exposures to low levels of endocrine active agents.
NIEHS and National Toxicology Program (NTP) are part of CLARITY-BPA (Consortium Linking Academic and Regulatory Insights on BPA Toxicity), an unprecedented collaboration that brings together academic researchers with federal regulators to answer critical research questions about BPA that will help inform regulatory decision-making.
The NTP, twelve NIEHS-supported grantees, and the Food and Drug Administration (FDA) are conducting the CLARITY–BPA study.
CLARITY-BPA incorporates a wide-range of doses and disease relevant endpoints which have not been used in any previous guideline-compliant BPA toxicity study. The study is ongoing.
Read more about CLARITY-BPA
- NIEHS/FDA CLARITY-BPA research program update(Reproductive Toxicology, December 2015)
- A new approach to synergize academic and guideline-compliant research: the CLARITY-BPA research program(Reproductive Toxicology, September 2013)
- Working Together: Research - and Science-Based Regulation of BPA(Environmental Health Perspectives, July 2013)
- Consortium-based science: the NIEHS’s Multi-pronged Collaborative Approach to Addressing the Health Effects of BPA(Environmental Health Perspectives, Dec 2012)
Environmental Factor Stories
- BPA grantees share findings(March 2013)
- NIEHS grantees collaborate with NTP, FDA on BPA studies(November 2011)
NIEHS Awarded Recovery Act Funds to Address Bisphenol A Research Gaps
NIEHS invested approximately $30 million on BPA-related research. This includes existing grants, the Recovery Act grants and supplements, in-house research and National Toxicology Program (NTP) projects. The NTP effort is part of a larger five-year commitment to collaborate with the U.S. Food and Drug Administration’s National Center for Toxicological Research to examine long-term health outcomes resulting from developmental exposures.
Researchers studying the health effects of the chemical bisphenol A (BPA) gathered in North Carolina in 2009 to launch an integrated research initiative to produce data that will allow for a comprehensive assessment of its possible human health effects.
Researchers who received funds from the American Recovery and Reinvestment Act to study BPA were brought together to meet with scientists from academia and government already working on the compound. The meeting was held Oct. 6, 2009 at the National Institute of Environmental Health Sciences (NIEHS).
Why did NIEHS use Recovery funds to support BPA research?
There is much uncertainty regarding the chemical BPA. BPA is used in certain food contact materials and was first approved by the FDA in the early 1960s. While recent assessments by authorities in the United States, Canada, Europe, and Japan agree that current food contact uses of BPA are safe, these assessments have identified the need to address data gaps. NIEHS wants to fill many of the research gaps in this area so informed personal and public health decisions can be made. For these reasons, NIEHS prioritized BPA research as a Signature initiative in the grants program undertaken with stimulus funds from the American Recovery and Reinvestment Act (ARRA). Some of the disease endpoints that Recovery Act-funded researchers will be investigating include behavior, obesity, diabetes, reproductive disorders, development of prostate, breast and uterine cancer, asthma, cardiovascular diseases and transgenerational or epigenetic effects.
What impact will the Recovery funding focused on BPA have?
The Recovery Act money will support the development of new data in a limited number of strategic areas where there is very little data. It will also help stimulate the replication and expansion of published studies that have been deemed by NTP/CERHR to have specific deficiencies. The goal of these ARRA funded grants is to produce both the animal and human data necessary to allow for a comprehensive assessment of the human health effects of BPA. Collectively, the results of these new ARRA funded studies and ongoing studies should begin to chip away at the uncertainties and research gaps and provide a better perspective of the potential threat that exposure to bisphenol A poses to public health.
What did NTP conclude in its 2008 monograph?
In September 2008, the National Toxicology Program (NTP) completed a review of available research on the chemical bisphenol A (BPA) and concluded that there was "some concern for effects on the brain, behavior, and prostate gland in fetuses, infants, and children at current human exposures."
Note that the possible levels of concern, from lowest to highest, are negligible concern, minimal concern, some concern, concern, and serious concern.
- The NTP has some concern for effects on the brain, behavior, and prostate gland in fetuses, infants, and children at current human exposures to bisphenol A.
- The NTP has minimal concern for effects on the mammary gland and an earlier age for puberty for females in fetuses, infants, and children at current human exposures to bisphenol A.
- The NTP has negligible concern that exposure of pregnant women to bisphenol A will result in fetal or neonatal mortality, birth defects, or reduced birth weight and growth in their offspring.
- The NTP has negligible concern that exposure to bisphenol A will cause reproductive effects in non-occupationally exposed adults and minimal concern for workers exposed to higher levels in occupational settings.
Read the report: The National Toxicology Program (NTP) Brief On Bisphenol A (BPA).
For basic information on bisphenol A, please see our health topic webpage on BPA.